The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Merck KGaA Plans to Considerably Expand Presence in Africa (2015-11-20)
> Aim is to more than double sales in Africa to about € 500 million by 2020 Merck, a leading science and technology company, announced today that it plans to considerably expand its presence on the African continent over the next five years and is counting on ...
- MeVis Medical Announces Results for Third Quarter of 2015 (2015-11-19)
> Sales in the third quarter increased by 33 % to € 4.8 m primarily due to the strong US dollar (prev. year: € 3.6 m) > Earnings before interest and taxes (EBIT) increased to € 3.6 m after nine month (prev. year € 3.2 m), EBIT margin of 30 % > Net profit decl...
- Merck, Univ of Cape Town Partner in Malaria Drug Discovery (2015-11-19)
> Private sector and academic center in Africa join forces in the fight against infectious diseases > Research collaboration leverages competencies and expertise in alignment with Merck’s commitment to improve access to medicines for underserved populations ...
- Probiodrug Reports Third Quarter 2015 Business Update (2015-11-19)
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), today announces its third quarter business update for the period ending 30 September 2015, in the form of an interim manag...
- Bertarelli and Viehbacher Launch Boston Pharmaceuticals (2015-11-19)
New Venture will Partner with Academic, Biotechnology and Biopharmaceutical Groups to Develop New Medicines Gurnet Point Capital, an investment firm focused on the healthcare and life sciences sectors that was founded by Ernesto Bertarelli and is led by Christ...
- Boston Pharmaceuticals Appoints Arroyo CMO, Chinoporos CBO (2015-11-19)
–Experienced Healthcare Executives Join Leadership Team to Further Build and Develop Portfolio– Boston Pharmaceuticals, a new fully integrated drug development company offering an innovative alternative model for drug development commercializiation, today anno...
- Merck KGaA Closes $17b Acquisition of Sigma-Aldrich (2015-11-18)
> New entity to enhance product range, capabilities and geographic reach > Customers benefit from a more than 300,000-product offering with highly-respected brands distributed through leading life science e-commerce and distribution platform > Organizational ...
- Sandoz: FDA Accepts Submission for Biosimilar Pegfilgrastin (2015-11-18)
Sandoz continues to advance its biosimilars program: Regulatory submission for Sandoz' proposed biosimilar pegfilgrastim accepted by the FDA > Sandoz demonstrates commitment to oncology by seeking approval for its proposed biosimilar pegfilgrastim. > ...
- Merck/Pfizer: FDA Breaktthrough Designation for Avelumab (2015-11-18)
> Breakthrough Therapy designation highlights the potential of avelumab* as a new immunotherapy for patients with metastatic Merkel cell carcinoma (MCC) > Metastatic MCC is a devastating disease and if approved, avelumab could potentially become the first immuno...
- Argenx Reports Third Quarter 2015 Financial Results (2015-11-17)
argenx (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today provided development program updates and announce...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)